玩股撇步(動畫小學堂)  

  • 營業利益和稅後淨利成長率大於營收成長率, 通常代表公司在成長, 如果是漲很多的股票, 發現沒有這個現象就要留意了
  • 營收到某個數字後, 營業利益產生不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)2090.00.00.28100.0300.00.21110.061.540.5796.55-8.0622.09.459.2930.752.645.711.5529.1728.10.5996.67321.437.7721.2245.235.2214.9838.16.2658.3455.00
23Q3 (19)2090.00.00.1416.67-41.670.100.0233.330.29107.14-47.2720.13.08-8.0529.96-0.9620.951.218.8153.850.320.0-40.06.4117.1815.54.546.8211.824.50258.33200.00
23Q2 (18)2090.00.00.12500.0-14.290.10400.000.14600.0-54.8419.55.92-26.9430.257.6538.191.0129.49-12.930.25525.0-10.715.4728.711.114.2532.42.91-1.31214.28157.69
23Q1 (17)2090.00.00.02-71.43-88.890.02-84.62-89.470.02-96.77-88.8918.41-8.54-11.6628.10-3.43.540.78-35.54-42.650.04-71.43-89.194.25-20.56-33.073.21-15.08-33.12-8.22-71.13124.35
22Q4 (16)2090.00.00.07-70.83-63.160.13333.33-31.580.6212.7344.1920.13-7.91-10.5729.0917.4431.11.2155.13-1.630.14-72.0-64.15.35-3.6-1.473.78-6.9-12.5-13.010.30166.66
22Q3 (15)2090.00.00.2471.4350.00.030400.00.5577.42120.021.86-18.12.0124.7713.1611.280.78-32.761.30.578.5751.525.552.595.314.06-1.695.454.9824.61-50.00
22Q2 (14)2090.00.00.14-22.22250.00.00-100.0100.00.3172.22244.4426.6928.0734.8721.89-19.34-10.731.16-14.7163.380.28-24.32300.05.41-14.830.364.13-13.9631.1110.32-13.74-50.00
22Q1 (13)2090.00.00.18-5.26260.00.190.0733.330.18-58.14260.020.84-7.4211.0327.1422.319.791.3610.57112.50.37-5.13236.366.3516.9447.334.8011.1149.07-1.196.751000.00
21Q4 (12)2090.00.00.1918.75-9.520.192000.0-5.00.4372.0186.6722.515.0431.7122.19-0.31-18.031.2359.7419.420.3918.18-11.365.433.04-12.984.3212.21-21.746.66159.381025.00
21Q3 (11)2090.00.00.16300.0128.57-0.0150.085.710.25177.78516.6721.438.2924.3822.26-9.22-12.020.778.451.320.33371.43135.715.2726.99-14.033.8522.22-3.276.86140.0041.66
21Q2 (10)2090.0-5.860.04-20.0200.0-0.0233.3375.00.0980.0169.2319.795.4320.7424.52-0.81-3.810.7110.9433.960.07-36.36177.784.15-3.7110.963.15-2.1747.897.63-48.09-40.84
21Q1 (9)2090.00.00.05-76.19155.56-0.03-115.072.730.05-66.67155.5618.779.8322.224.72-8.68-3.10.64-37.86156.00.11-75.0161.114.31-30.93129.263.22-41.67329.334.5161.91135.35
20Q4 (8)2090.00.00.21200.0162.50.20385.71900.00.15350.0-50.017.09-0.81-4.5827.077.02.151.0335.5317.050.44214.29158.826.241.7910.445.5238.6956.372.16237.50199.10
20Q3 (7)209-5.860.00.07275.0-50.0-0.0712.5-450.0-0.0653.85-127.2717.235.13-8.325.30-0.7510.670.7643.443.40.14255.56-51.726.1363.950.613.9886.8547.965.92165.2819.88
20Q2 (6)2226.226.22-0.0455.56-233.33-0.0827.27-188.89-0.13-44.44-262.516.396.71-9.0525.49-0.082.120.53112.0-17.19-0.0950.0-228.573.7498.9430.772.13184.028.31-3.77-78.47-311.37
20Q1 (5)2090.00.0-0.09-212.5-280.0-0.11-650.0-650.0-0.09-130.0-280.015.36-14.24-12.3325.51-3.746.070.25-71.59-55.36-0.18-205.88-280.01.88-66.73-46.290.75-78.75-66.96--0.00
19Q4 (4)2090.00.00.08-42.860.00.020.00.00.3036.360.017.91-4.680.026.5015.920.00.8866.040.00.17-41.380.05.6538.820.03.5331.230.0--0.00
19Q3 (3)2090.00.00.14366.670.00.02-77.780.00.22175.00.018.794.270.022.86-8.410.00.53-17.190.00.29314.290.04.0742.310.02.6962.050.0--0.00
19Q2 (2)2090.00.00.03-40.00.00.09350.00.00.0860.00.018.022.850.024.963.780.00.6414.290.00.07-30.00.02.86-18.290.01.66-26.870.0--0.00
19Q1 (1)2090.00.00.050.00.00.020.00.00.050.00.017.520.00.024.050.00.00.560.00.00.10.00.03.500.00.02.270.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/26.33-15.7210.5913.8312.2322.22N/A-
2024/17.51-10.5313.667.5113.6622.45N/A-
2023/128.3928.0121.6579.89-10.521.980.67-
2023/116.55-6.795.2971.5-13.220.170.73-
2023/107.036.838.7364.95-14.7120.440.72-
2023/96.58-3.52-12.2857.92-16.8820.020.71-
2023/86.823.07-9.6151.34-17.4420.850.68-
2023/76.62-10.66-7.1744.51-18.5220.380.7-
2023/67.4116.62-5.3837.89-20.2219.450.61-
2023/56.3511.76-50.8230.48-23.1518.160.66因子公司杏昌生技去年同期有新增快篩試劑銷售本年度因疫情趨緩銷售減少
2023/45.68-7.13-4.6724.13-9.7917.530.68-
2023/36.127.01-15.0318.45-11.2718.450.7-
2023/25.72-13.386.9512.32-9.2719.220.67-
2023/16.6-4.24-19.816.6-19.8119.730.65-
2022/126.910.79-14.1189.288.5519.590.68-
2022/116.22-3.74-6.5182.3811.0120.20.66-
2022/106.47-13.81-17.2376.1512.7321.520.62-
2022/97.5-0.58-3.1169.6916.6522.180.69-
2022/87.555.850.362.1819.622.510.68-
2022/77.13-8.9419.0454.6322.8727.880.55-
2022/67.83-39.3810.747.523.4626.720.52-
2022/512.92116.65122.039.6726.3326.090.53合併子公司杏昌生技業務增加
2022/45.96-17.22-14.026.754.5718.520.75-
2022/37.234.715.3620.7911.4820.790.6-
2022/25.35-35.06-6.5913.5815.0321.610.58-
2022/18.242.5535.398.2435.3922.920.55-
2021/128.0320.5922.3882.2424.8822.50.64-
2021/116.66-14.7720.5874.2125.1622.220.65貿易出貨成長
2021/107.810.8863.6367.5525.6323.080.62貿易營收成長
2021/97.752.9135.9359.7421.9321.260.62-
2021/87.5325.6326.5451.9920.0820.590.64貿易出貨成長
2021/75.99-15.326.3944.4619.0618.880.7-
2021/67.0721.5515.4538.4821.319.830.6-
2021/55.82-16.0811.1631.422.7119.590.61-
2021/46.931.4137.6725.5825.6819.50.61-
2021/36.8419.4238.5518.6521.7318.650.63109年受疫情影響偏低
2021/25.73-5.8628.8911.8113.7418.370.64109年2月因疫情影響,致營收明顯偏低。
2021/16.08-7.292.416.082.4118.170.64-
2020/126.5618.81-9.4865.85-8.8716.860.64-
2020/115.5215.644.0659.29-8.815.990.67-
2020/104.77-16.19-10.3553.77-9.9516.420.66-
2020/95.7-4.19-5.5748.99-9.9117.280.61-
2020/85.955.63-9.2643.29-10.4517.70.6-
2020/75.63-8.11-10.7437.35-10.6416.990.62-
2020/66.1317.03-2.7531.72-10.6216.40.58-
2020/55.243.93-4.2325.59-12.3215.210.62-
2020/45.042.06-20.420.35-14.1814.410.65-
2020/34.9411.09-14.8115.32-11.9215.320.64-
2020/24.44-25.19-0.9110.38-10.4717.630.55-
2020/15.94-18.06-14.495.94-14.4918.490.53-
2019/127.2536.5914.8372.264.3917.880.56-
2019/115.31-0.37-4.0965.023.3416.670.61-
2019/105.33-11.72-0.4459.714.0617.920.56-
2019/96.03-7.94-4.4154.384.5218.90.52-
2019/86.553.914.8648.355.7619.160.51-
2019/76.310.111.3741.795.918.080.54-
2019/66.315.266.335.494.9818.10.54-
2019/55.47-13.62-4.5829.194.717.590.56-
2019/46.339.2314.3923.727.10.0N/A-
2019/35.7929.22-4.1417.394.680.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)2090.00.56-9.680.4319.4480.01-10.6229.8217.264.550.894.85-4.151.19-8.46
2022 (9)2090.00.6244.190.36176.9289.528.5125.438.954.5134.635.0627.141.342.86
2021 (8)2090.00.43186.670.13082.524.8723.34-9.713.3529.843.9831.790.91203.33
2020 (7)2090.00.15-50.0-0.07066.07-8.5525.855.172.58-1.153.023.780.3-52.38
2019 (6)2090.00.3076.470.16072.254.1724.587.292.6136.652.9111.490.6375.0
2018 (5)2090.00.17-5.56-0.16069.36-2.6522.91-2.761.91-37.792.61-11.220.36-7.69
2017 (4)2090.00.18-60.870.25-55.3671.257.5323.564.93.0718.532.9423.010.39-59.79
2016 (3)2090.00.46-8.00.56-20.066.2612.422.462.142.5929.52.3950.310.97-7.62
2015 (2)2090.00.50-48.450.7012.958.95-6.3421.99-1.082.0-3.381.59-43.211.05-48.28
2014 (1)209-4.570.97110.870.62062.940.7422.2302.07459.462.894.442.03100.99

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。